focus -WSS

focus

author：explore 2025-10-02 12:32:33 - browse：7

Illumina, the leading maker of DNA sequencing machines, said Sunday that it would divest Grail, the developer of a multi-cancer screening test, which it bought over the objections of regulators in the U.S. and Europe in August 2021.

Illumina said the decision to spin Grail off followed a Friday decision of the U.S. Fifth Circuit Court of Appeals, which held that the merger was anti-competitive. It said that it would divest Grail either by selling it to another company or listing it on capital markets, consistent with an order from the European Commission, and that it aims to finalize the terms of the deal by the end of the second quarter of 2024.

The decision opens what should be the final chapter in one of the most disastrous attempted mergers in biotech history. Illumina, a storied name that had delivered investors strong returns over two decades, spun out Grail in 2016 in order to raise money to fund the company’s work. Then, it announced plans to re-acquire the firm for $7.1 billion in Sept. 2020.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： BridgeBio heart drug succeeds in pivotal study

WSS

GOP inquiry over gain

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Biden administration sends mixed signals on US soldier who crossed into North Korea

Robert Kennedy Jr.'s presidential campaign attracts GOP

Robert Kennedy Jr.'s presidential campaign attracts GOP

The simple reason for the increase in autism diagnosis

leisure time

focus

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A look at other Americans who have crossed into North Korea over the years

Jerome Adams on the need for new antivirals for Covid

Medical experts exlpore how to eliminate bias in clinical algorithms

Medical leaders decry Supreme Court decision on affirmative action

What we know about the American soldier detained in North Korea

Apple is now the first public company to be valued at $3 trillion

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

As demand for Covid shots wanes, Moderna seeks its next success

A strong 6.5

focus

Manchin plays down potential 3rd

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

FDA seeking to stop procedures at two unregulated stem cell clinics

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

FDA seeking to stop procedures at two unregulated stem cell clinics

GOP inquiry over gain

entertainment

knowledge

hotspot

leisure time